Novartis AG vs Wix.Com Ltd — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Wix.Com Ltd trades at $53.52 (market cap $2.23B). The key difference: Novartis AG is far larger — about 130.2× Wix.Com Ltd's market cap, and Novartis AG pays a 3.17% dividend while Wix.Com Ltd pays none. Which is the better fit depends on your goals.
| NVS | WIX | |
|---|---|---|
Market Cap | $290.25B | $2.23B |
Sector | Health | Technology |
52-Week High | $168.62 | $184.24 |
52-Week Low | $113.50 | $40.43 |
Enterprise Value | $330.27B | $1.80B |
Dividend Yield | 3.17% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Wix.com Ltd is a cloud-based development platform provider for millions of registered users worldwide. The company is engaged in web development and management that provides an easy-to-use powerful cloud-based platform of products through a freemium model. Its core products consist of three web editors: the Wix Editor, intended for users with basic technological skills, Wix ADI, intended for novice users and Corvid, intended for more tech-savvy users. The company's web development technology is built based on HTML5 and offers HTML5 compatible capabilities, web design and layout tools, domain hosting, and other marketing and workflow management applications and services. The geographic segments include North America, Europe, Latin America, Asia and others.
Read more on WIX →